Correlation Between Royalty Pharma and Ocean Biomedical
Can any of the company-specific risk be diversified away by investing in both Royalty Pharma and Ocean Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royalty Pharma and Ocean Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royalty Pharma Plc and Ocean Biomedical, you can compare the effects of market volatilities on Royalty Pharma and Ocean Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royalty Pharma with a short position of Ocean Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royalty Pharma and Ocean Biomedical.
Diversification Opportunities for Royalty Pharma and Ocean Biomedical
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Royalty and Ocean is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Royalty Pharma Plc and Ocean Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocean Biomedical and Royalty Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royalty Pharma Plc are associated (or correlated) with Ocean Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocean Biomedical has no effect on the direction of Royalty Pharma i.e., Royalty Pharma and Ocean Biomedical go up and down completely randomly.
Pair Corralation between Royalty Pharma and Ocean Biomedical
Given the investment horizon of 90 days Royalty Pharma Plc is expected to generate 0.33 times more return on investment than Ocean Biomedical. However, Royalty Pharma Plc is 3.01 times less risky than Ocean Biomedical. It trades about 0.43 of its potential returns per unit of risk. Ocean Biomedical is currently generating about -0.01 per unit of risk. If you would invest 2,428 in Royalty Pharma Plc on October 20, 2024 and sell it today you would earn a total of 647.00 from holding Royalty Pharma Plc or generate 26.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Royalty Pharma Plc vs. Ocean Biomedical
Performance |
| Timeline |
| Royalty Pharma Plc |
| Ocean Biomedical |
Royalty Pharma and Ocean Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Royalty Pharma and Ocean Biomedical
The main advantage of trading using opposite Royalty Pharma and Ocean Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royalty Pharma position performs unexpectedly, Ocean Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will offset losses from the drop in Ocean Biomedical's long position.| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
| Ocean Biomedical vs. Enveric Biosciences | Ocean Biomedical vs. Hepion Pharmaceuticals | Ocean Biomedical vs. Elevation Oncology | Ocean Biomedical vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |